Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1945
Full metadata record
DC FieldValueLanguage
dc.contributorHu, Chih-Chiangen_US
dc.contributorLow, Ashleaen_US
dc.contributorO'Connor, Ellieen_US
dc.contributorSiriratnam, Pakeeranen_US
dc.contributorHair, Caseyen_US
dc.contributorKraemer, Thomasen_US
dc.contributorSahathevan, Rameshen_US
dc.date.accessioned2022-06-01T23:32:42Z-
dc.date.available2022-06-01T23:32:42Z-
dc.date.issued2022-
dc.identifier.govdoc01879en_US
dc.identifier.urihttp://hdl.handle.net/11054/1945-
dc.description.abstractBackground Stroke and diabetes mellitus (DM) are significant interrelated healthcare issues but there is a dearth of data on the prevalence of DM among Australia's regional stroke population. Aims We aimed to determine the prevalence of DM in stroke patients at a large regional centre, including subanalyses on stroke subtypes, glycaemic control and renal function in ischaemic stroke (IS). Methods We conducted a retrospective analysis of all patients (n = 323) with IS or transient ischaemic attack (TIA) admitted to Ballarat Base Hospital from January 2015 to December 2016. Demographic data, cardiovascular risk factors, aetiology/territory of IS, pre-morbid DM status, indicators of glycaemic control and renal impairment were recorded. Results DM was present in 28.5% of IS and TIA patients, including 4% being newly diagnosed. Among diabetic IS patients, 45.3% had poor glycaemic control (HbA1c ≥7.0%) while 16% had moderate to severe renal impairment (estimated glomerular filtration rate of <30). The majority of IS were partial anterior circulation stroke (53.4%) and cardioembolism was the commonest mechanism (43.5%). We found no significant association between DM and a specific stroke location or mechanism. Conclusions Almost one-third of IS/TIA patients had DM, with a significant proportion showing poor glycaemic control. The DM prevalence in our cohort was comparable with reported rates from other developed countries. Although we found no association between DM and a particular stroke type or mechanism, it is likely a reflection of our cohort size. Our study demonstrated that DM, as a significant risk factor in IS, warrants early detection and better management strategies.en_US
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2022-05-05T01:41:24Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2022-06-01T23:32:42Z (GMT) No. of bitstreams: 0en
dc.description.provenanceMade available in DSpace on 2022-06-01T23:32:42Z (GMT). No. of bitstreams: 0 Previous issue date: 2022en
dc.titleDiabetes in ischaemic stroke in a regional Australian hospital: uncharted territory.en_US
dc.typeJournal Articleen_US
dc.type.specifiedArticleen_US
dc.bibliographicCitation.titleInternal Medicine Journalen_US
dc.bibliographicCitation.volume52en_US
dc.bibliographicCitation.issue4en_US
dc.bibliographicCitation.stpage574en_US
dc.bibliographicCitation.endpage580en_US
dc.subject.healththesaurusISCHAEMIC STROKEen_US
dc.subject.healththesaurusTRANSIENT ISCHAEMIC ATTACKen_US
dc.subject.healththesaurusDIABETESen_US
dc.subject.healththesaurusPREVALENCEen_US
dc.subject.healththesaurusDIABETIC COMPLICATIONen_US
dc.subject.healththesaurusNON-METROPOLITAN POPULATIONen_US
dc.identifier.doihttps://doi.org/10.1111/imj.15073en_US
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.